Article

Decreasing Risk of Diabetic Ketoacidosis in Children: Keeping Appointments

Managing of type 1 diabetes mellitus (T1DM) is a full-time job.

Management of type 1 diabetes mellitus (T1DM) is a full-time job, and in addition to the day-to-day management, T1DM patients face a higher risk of diabetic ketoacidosis (DKA), the primary cause of morbidity and mortality among children with T1DM.

A new study published in the June 2016 Journal of Pediatrics indicated that recent emergency department (ED) visits and missed quarterly endocrinologist appointments could help predict DKA hospitalizations.

Researchers from the Stanford University School of Medicine conducted a retrospective analysis of children with T1DM enrolled in California Children’s Services (CCS), a form of Medicaid.

The study reviewed paid claims for 5263 enrolled children from 2009 to 2012 for exposure to 2 types of outpatient care: (1) maintenance care and (2) acute care. Of those enrolled, 878 (16.7%) children were hospitalized during the study period.

A novel finding in this study was that patients who were seen at an ED had an increased likelihood of DKA during the next 14 days. This suggested that timely outpatient appointments should be made to prevent possible hospitalization.

The second major finding was that patients who had missed a quarterly endocrinology visit (within the last 120 days) had a higher risk of DKA hospitalization. This finding supports a 1997 study by the Joslin Diabetes Center and shows a need of future research in different patient populations to strengthen the associations.

The author suggested that more than 50% of diabetic children were not meeting the recommendation for quarterly subspecialty care for various reasons. Missed appointments should trigger management strategies aimed to prevent DKA, such as renewed education, care coordination, and patient- or family-focused behavioral interventions.

The team acknowledged that further research into the role of outpatient care and the prevention of DKA is needed to verify their findings and to provide guidelines that will improve care and outcomes for these patients.

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.